Cargando…
Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
We report a case of refractory idiopathic childhood pyoderma gangrenosum in a young boy who had suffered from this disease since 3 years of age. He had unfavorable responses and intermittent relapses under different combinations of cytotoxic and steroid therapies. Although there was not much informa...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554516/ https://www.ncbi.nlm.nih.gov/pubmed/31239637 http://dx.doi.org/10.2147/BTT.S203753 |